Showing results (251-260 of 31,336) with videos related to
Sort By:
Pageof 3,134
Journal of Medicinal Chemistry|February 10, 2011
Discovery of potent inhibitors of soluble epoxide hydrolase by combinatorial library design and structure-based virtual screeningLi Xing, Joseph J McDonald, Steve A Kolodziej, et al.Journal of Medicinal Chemistry|March 31, 2011
Design and synthesis of novel N-hydroxy-dihydronaphthyridinones as potent and orally bioavailable HIV-1 integrase inhibitorsTed W Johnson, Steven P Tanis, Scott L Butler, et al.Journal of Medicinal Chemistry|August 1, 1990
4-Isoxazolyl-1,4-dihydropyridines: biological, theoretical, and structural studiesN R Natale, D J Triggle, R B Palmer, et al.Journal of Medicinal Chemistry|April 20, 2019
Structure-Guided Drug Design of 6-Substituted Adenosine Analogues as Potent Inhibitors of Mycobacterium tuberculosis Adenosine KinaseRoberto A Crespo, Qun Dang, Nian E Zhou, et al.Journal of Medicinal Chemistry|April 23, 2019
Exploitation of Antibiotic Resistance as a Novel Drug Target: Development of a β-Lactamase-Activated Antibacterial ProdrugLindsay E Evans, Aishwarya Krishna, Yajing Ma, et al.Journal of Medicinal Chemistry|January 1, 1979
A new nonsteroidal analgesic-antiinflammatory agent. Synthesis and activity of 4-ethoxy-2-methyl-5-morpholino-3(2H)-pyridazinone and related compoundsM Takaya, M Sato, K Terashima, et al.Journal of Medicinal Chemistry|May 24, 2019
Five-Membered N-Heterocyclic Scaffolds as Novel Amino Bioisosteres at γ-Aminobutyric Acid (GABA) Type A Receptors and GABA TransportersAlessandro Giraudo, Jacob Krall, Francesco Bavo, et al.Journal of Medicinal Chemistry|May 24, 2019
Design and Synthesis of Potent, Selective Inhibitors of Protein Arginine Methyltransferase 4 against Acute Myeloid LeukemiaZuhao Guo, Zhuqing Zhang, Hong Yang, et al.Journal of Medicinal Chemistry|May 7, 2019
Synthesis of Shld Derivatives, Their Binding to the Destabilizing Domain, and Influence on Protein Accumulation in Transgenic PlantsFrederik Præstholm Jørgensen, Daniel Madsen, Morten Meldal, et al.Journal of Medicinal Chemistry|May 7, 2019
Design and Discovery of N-(3-(2-(2-Hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide, a Selective, Efficacious, and Well-Tolerated RAF Inhibitor Targeting RAS Mutant Cancers: The Path to the ClinicSavithri Ramurthy, Benjamin R Taft, Robert J Aversa, et al.Pageof 3,134